Skip to Content
Merck

Key Documents

View All Documentation

317632

(Methylcyclopentadienyl)manganese(I) tricarbonyl

liquid

Synonym(s):

(Methylcyclopentadienyl)tricarbonylmanganese, MCMT, Tricarbonyl(2-methylcyclopentadienyl)manganese, Ethyl MMT, MMT, NSC 22316

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
C5H4CH3Mn(CO)3
CAS Number:
12108-13-3
Molecular Weight:
218.09
NACRES:
NA.22
PubChem Substance ID:
24859093
UNSPSC Code:
12161600
EC Number:
235-166-5
MDL number:
MFCD00001426
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

(Methylcyclopentadienyl)manganese(I) tricarbonyl,

vapor density

>1 (vs air)

Quality Level

100

vapor pressure

0.05 mmHg ( 20 °C)

form

liquid

reaction suitability

core: manganese, reagent type: catalyst

refractive index

n20/D 1.584 (lit.)

bp

232-233 °C (lit.)

mp

−1 °C (lit.)

density

1.38 g/mL at 25 °C (lit.)

SMILES string

[Mn].[C-]#[O+].[C-]#[O+].[C-]#[O+].C[C]1[CH][CH][CH][CH]1

InChI

1S/C6H7.3CO.Mn/c1-6-4-2-3-5-6;3*1-2;/h2-5H,1H3;;;;

InChI key

LYHJNAIHGFWRKM-UHFFFAOYSA-N

General description

Methylcyclopentadienyl manganese tricarbonyl (MMT) is commonly used as an antiknock agent in gasoline. It is also used as an additive in unleaded gasoline.

Application

Methylcyclopentadienyl manganese tricarbonyl can be used for doping of ZnSe nanocrystals.
It can also be used as a reactant for:
  • Aldol addition reactions.
  • Preparation of homo- and heteronuclear mixed biscarbene complexes with conjugated bithiophene units.
  • Molecular fragmentation using shaped femtosecond laser pulses.
  • Preparation of MnAs thin films grown on GaAs(001) by metalorganic vapour phase epitaxy (MOVPE).

signalword

Danger

Hazard Classifications

Acute Tox. 1 Inhalation - Acute Tox. 2 Dermal - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Skin Irrit. 2 - STOT RE 1 Inhalation

target_organs

Lungs

Storage Class

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

wgk

WGK 3

flash_point_f

204.8 °F - closed cup

flash_point_c

96 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

Class I Designated Chemical Substances

prtr

Group 4: Flammable liquids + Type 3 petroleums + Hazardous rank III + Water insoluble liquid

fsl

Substances Subject to be Indicated Names

ishl_indicated

Substances Subject to be Notified Names

ishl_notified

317632-50G:4.548173961248E12 + 317632-1G:4.548173961231E12

jan

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
07196TJ
09301EJ
08924ME
16031ED
14110DT

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Afsaneh Nouri et al.
International journal of biological macromolecules, 109, 1219-1231 (2017-11-25)
Montmorillonite -copper oxide (MMT-CuO) nanocomposites were prepared by a facile and eco-friendly method and introduced into chitosan (Cs) matrix to enhance its optical, mechanical and antibacterial properties. The synthesized composites were characterized using diffuse reflectance spectroscopy (DRS), X-ray diffraction (XRD)
Properties of homo- and heteronuclear mixed biscarbene complexes with conjugated bithiophene units
Landman, M.; et al.
Inorgorganica Chimica Acta, 363, 705-705 (2010)
Einat Peles et al.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 15(8), 620-628 (2014-03-29)
Methadone maintenance treatment (MMT) patients may achieve up to a 2-week privilege of methadone take-home doses (THD), which is associated with considerable responsibility. MMT patients are characterized as having poor sleep quality and low cognitive states. We studied sleep indices
View All Related Papers